Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Cost of Adherence: Shared Financial Incentives Lead to LDL Cholesterol Reductions

For patients with cardiovascular disease, the cost of not taking prescribed medications can be worse outcomes, increased hospitalization and even death. Nevertheless, about half of patients who are prescribed statins stop taking them within a year.

Medtronic updates guidance and announces capital allocation plans

Medtronic announced on Jan. 11 that it will return $5 billion to shareholders through share repurchases by the end of fiscal year 2018.

University of Oxford spinout raises money to develop brain aneurysm device

Oxford Endovascular, a medical device company spinout from the University of Oxford in England, has raised £2m (approximately $2.9 million) to develop a small metallic mesh tube to treat intracranial aneurysms.

Thumbnail

Watchman device may be cost-effective, but more research is needed

A recent study suggests the Watchman may save money and be more cost-effective than novel oral anticoagulants in the long-run.

Ohio cardiologist is sentenced to 20 years for overbilling

Harold Persaud, MD, a cardiologist from Ohio, was sentenced to 20 years in prison on Dec. 18 for overbilling Medicare and private insurance companies by $29 million between 2006 and 2012. The Department of Justice announced the sentence on Dec. 18.

Thumbnail

Model finds Watchman device is more cost-effective than warfarin and oral anticoagulants

A model found that treatment with novel oral anticoagulants or the Watchman device were more cost-effective than warfarin to reduce the lifetime stroke risk of patients with nonvalvular atrial fibrillation.

Medtronic increases cash dividend for the third quarter of fiscal year 2016

Medtronic announced on Dec. 11 that it would pay a cash dividend of $0.38 per ordinary share for the third quarter of fiscal year 2016.

Thumbnail

Medtronic’s revenue increases, net income declines in 2Q of fiscal year 2016

For the second quarter of fiscal year 2016, Medtronic’s revenue increased 6 percent and its net income decreased 37 percent compared with the same period last year. Results were released on Dec. 3.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.